Bayer AG has patented new potassium channel Kir3.4 (GIRK4; KCNJ5) and/or Kir3.1/3.4 (GIRK1/4; KCNJ3/5) blockers potentially useful for the treatment of heart failure, arrhythmia, primary ...
Suffer from sleep apnea? A bedtime nasal spray that lowers blood pressure could be the solution. The results of a study published in the American Journal of Physiology’s Journal of Heart and ...
Australian researchers have discovered that a bedtime nasal spray has the potential to reduce the severity of sleep apnea in people and lower their blood pressure. The new research published in The ...
Researchers at Semmelweis University and University of Szeged have disclosed aminoalkylated benzoxy compounds acting as potassium channel blockers reported to be useful for the treatment of atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results